RSS | ATOM

BDEAN

 
  • Fri
  • 11/6/2009
  • 12:36 PM
  • Woos
    & Boos
  • 0
    WOOS
  • 0
    BOOS
  • BMGP, AMNP, DVME, PAYI, JAGR, SSHS, CBBO, ACLS, CBAI, EDVP, SNSS OTCPicks.com Daily Market Movers Digest Midday Report for Friday, November 6th

     



    Our Stocks to Watch
    today include Biomagnetics Diagnostics Corp. (OTC: BMGP), American Sierra Gold
    Corp. (OTCBB: AMNP), Diverse Media Group Inc. (OTC: DVME), Pay88 Inc. (OTCBB:
    PAYI), Jaguar Mining Enterprises Inc. (OTC: JAGR), Safeguard Security Holdings
    Inc. (OTC: SSHS), Columbia Bancorp Corp. (Nasdaq: CBBO), Axcelis Technologies
    Inc. (Nasdaq: ACLS), Cord Blood America Inc. (OTCBB: CBAI), Endeavor Power
    Corp. (OTCBB: EDVP) and Sunesis Pharmaceuticals Inc. (Nasdaq: SNSS).



     



    Visit http://www.otcpicks.com/microcap.htm
    to register for our Daily Market Mover’s Digest Newsletter and Email Stock
    Watch Alerts.



     



    BIOMAGNETICS
    DIAGNOSTICS CORPORATION (OTC: BMGP)



     



    Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php 



     



    Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm



     



    Biomagnetics
    Diagnostics Corporation is an advanced medical device and biotechnology
    company. The Company's revolutionary diagnostic systems, which are based on
    advanced magnetics, test for any viral or bacterial disease using any body
    fluid. The Company's technology allows laboratories to perform far more tests
    in the same amount of time it takes to do a single test. The HTS-MTP platform
    is designed to detect the actual virus and viral load in body fluids and not
    just simply screen for the presence of viral antibodies.



     



    BMGP News:



     



    November 4 -
    Biomagnetics Applies for Gates Foundation Grand Challenge Grant



     



    Biomagnetics
    Diagnostics Corp. (OTC: BMGP), a developer of revolutionary diagnostic systems
    and technology for HIV, hepatitis, tuberculosis, and malaria detection,
    announced it has submitted an application to the Bill & Melinda Gates
    Foundation for a grant to further develop the Integrate Optical Biosensor
    Sensor (IOBS) technology it is plans to bring to market. The topic for the
    Grand Challenge Grant is Low Cost Diagnostics for Global Priory Health
    Conditions, which includes both malaria and tuberculosis.





    “The availability of
    low cost diagnostics for malaria and tuberculosis are major concerns for not
    only health care professions, but also for the Gates Foundation. The technology
    we plan to introduce reduces the cost of traditional malaria testing by up to
    two-thirds,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “The
    IOBS platform produces test results measured in only minutes, whereas
    traditional methodologies often take many days. Additionally, the handheld IOBS
    platform can be utilized in the field at point of care by relatively untrained
    personnel. We believe the IOBS platform holds the promise to revolutionize
    testing for not only malaria, but also for many other diseases including
    tuberculosis and HIV/AIDS. We believe the Gates Foundation had a device such as
    IOBS in mind when it devised the specifications for the Challenge Grant.”



     



    According to the
    World Health Organization, some 3.2 billion people, or about half the world's
    population is at risk of malaria transmission in 107 countries and territories
    worldwide. While there are between 350 million and 500 million new cases of
    malaria each year, there are very few reliable and field deployable diagnostic
    tools available. In the case of malaria, early detection substantially improves
    treatability and survivability. Field deployable Integrated Optical Biosensor
    Systems (IBOS), such those Biomagnetics Diagnostics is planning to soon
    introduce hold the promise to significantly speed the diagnostic testing
    process and to meaningfully lower costs and improve lives.



     



    AMERICAN SIERRA GOLD
    CORPORATION (OTCBB: AMNP)



     



    Detailed Quote: http://www.otcpicks.com/quotes/AMNP.php



     



    Company Profile: http://www.otcpicks.com/american-sierra-gold/american-sierra-gold.htm



     



    American Sierra Gold
    Corp. is a publicly traded independent gold exploration company headquartered
    in Reno, Nevada.
    Shareholders and prospective investors are encouraged to call investor
    relations at 1-888-279-3921 or visit American Sierra Gold Corp's website at
    www.americansierragold.com.



     



    AMNP News:



     



    November 5 - Cohen
    Independent Research Group Issues a 'Buy' Rating With a Target Price of $3.21
    for American Sierra Gold Corp.



     



    American Sierra Gold
    Corp. (OTCBB: AMNP), an independent gold exploration company headquartered in
    Reno, Nevada, announces that Cohen Independent Research Group, Inc., Wall
    Street's leading independent fundamental research firm, has issued a research
    report on American Sierra with a "buy" recommendation and a long-term
    target price of $3.21.



     



    For the full report,
    visit Cohen Independent Research Group's website, www.cohenresearch.com or
    visit American Sierra's website, www.americansierragold.com.



     



    DIVERSE MEDIA GROUP
    INCORPORATED (OTC: DVME)



     



    Detailed Quote: http://www.otcpicks.com/quotes/DVME.php 



     



    Company Profile: http://otcpicks.com/Newsletter/DVME_eProfile_091709.html  



     



    Diverse Media Group,
    Inc. is an entertainment company that aggregates expertise across all aspects
    of the media industry. Diverse Media Group has at its core the established
    27-year history of its wholly owned subsidiary, Diverse Talent Group. Diverse
    Talent Group is now the 10th largest Hollywood
    agency offering talent and literary representation in commercials, episodic
    television, cable programming and motion pictures. The company has the ability
    to create programming, foster distribution and represent talented individuals
    to fuel a new digital age of content generation. The parent company also
    includes the subsidiary Talent Quest America, Inc., which identifies new and
    rising talent representing the future of the Hollywood
    entertainment community.



     



    DVME News:



     



    September 28 -
    Network Talks Underway to Develop 'Momo' into Weekly TV Series Title is Part of
    Diverse Media Group, Inc. Option Agreement with Elio Pictures



     



    “Momo” executive
    producers Dimitri Logothetis and Nicholas Celozzi have announced that talks are
    underway with networks in the U.S.
    and Canada
    to develop the project as a weekly series for television. “Momo” is one of six
    titles for which Diverse Media Group, Inc. (OTC: DVME) has optioned to purchase
    a 30% interest from Elio Pictures, Ltd.



     



    Diverse Media Group
    CEO Chris Nassif calls the development “a huge step forward in our company’s
    transition to a complete entertainment and media services provider.”



     



    Logothetis and
    Celozzi have been working for seven years on the life story of infamous mob
    boss Sam Giancana. After securing the exclusive story rights from Francine
    Giancana to her father’s life story, they originally set the project up at
    Warner Bros. and Turner as a mini-series. Logothetis calculates development
    costs to date at $75,000. With the success of the 60's-based AMC series “Mad
    Men,” they decided that “Momo” could also satisfy weekly audience interest in
    that period of Americana.
    Giancana was born in 1908 and killed in 1974.



     



    Celozzi describes the
    series as real-life “Sopranos” meets “The Gangster Chronicles.” Sam Giancana
    was a very compelling personality. As a family man, Sam lost his wife to a
    rheumatic heart disease, raised three daughters, supported an extended family
    and was one of the most powerful men of the twentieth century. Through union
    ties Giancana helped swing the Illinois
    vote during the Kennedy/Nixon election. He was the first mobster to claim his
    rights to the Fifth Amendment in front of live television cameras while
    questioned by Bobby Kennedy during the McClellan committee hearings. Sam had a
    long-standing friendship with Frank Sinatra, the leader of the so called “Rat
    Pack,” who played in Chicago
    nightclubs run by Giancana.



     



    The other Elio
    Pictures titles optioned by Diverse Media Group include “The Lost Angel” (2005)
    with Judd Nelson and Celozzi, “Framed by Seduction” (2004) starring Robert
    Patrick, “Nightmare Boulevard
    (2004) starring Claudia Christian and Corbin Bernsen, “7-10 Split” (2007)
    featuring Tara Reid and Rachel Hunter, and “Senior Skip Day” (2008) with Lea
    Thompson and Norm MacDonald.



     



    The option is being
    purchased with 25 million shares of Diverse Media Group restricted common
    stock, valued at $50,000. The Company has until March 30, 2010, to exercise its
    option for a cash price of an additional $400,000.



     



    PAY88 INCORPORATED
    (OTCBB: PAYI)



     



    Detailed Quote: http://www.otcpicks.com/quotes/PAYI.php 



     



    Company Profile: http://www.otcpicks.com/pay88-inc/pay88-inc.htm



     



    Pay88, Inc., through
    its wholly-owned subsidiary, Chongqing Qianbao Technology, Ltd., is a rapidly
    growing digital technology company and the leading reseller of internet game
    time in China
    with over $19.7 million USD in revenues in 2008, a 134.8% increase over
    revenues in 2007. The company is primarily engaged in the sale of prepaid
    online multi-player game cards in more than 20 cities in China, an
    industry that generated $2.75 billion in 2008 and is expected to reach $3.8
    billion by the end of 2009. In addition, The Company sells prepaid telephone
    cards and over 800 software products, including cooking, language and education
    software. Qianbao sells its game cards through its websites, www.iamseller.com,
    and www.17logo.com, which has more than 1 million registered users. The Company
    has successfully captured more than 80% of the online multi-player game time
    market in Chongqing, a municipality of more than
    31 million people, and the third fastest-growing regional economy in China. Pay88
    leverages such consumer establishments as retail kiosks and Internet cafes to
    increase its distribution of highly popular games for an increasing number of
    gaming companies.



     



    PAYI News:



     



    October 28 - Pay88,
    Inc. Goes Mobile
    With Sohu.com Inc.



     



    Pay88, Inc. (OTCBB:
    PAYI) announced that it has entered into a distribution agreement with Sohu.com
    Inc. (Nasdaq: SOHU). Through its subsidiary, Qianbao Technology, Pay88 will act
    as a distributor of SOHU digital products, with a particular focus on mobile
    phone games.



     



    With more than 100
    million users and 700 million site visits per day, Sohu.com Inc., is one of the
    leading internet media companies in China with revenues of over $429 million
    USD in 2008, 2.3 times that of .scal 2007. Sohu provides millions of Chinese
    consumers with information, communication and entertainment services through
    its matrix of websites and offers two types of consumer services — online games
    (including the massively popular multi-player online role-playing games
    "Tian Long Ba Bu" and "Blade Online"), and wireless
    connectivity.



     



    Pay88 is one of the
    few companies in China
    capable of facilitating online banking and is also the leading reseller of
    internet game time in China's
    booming $2.75 billion online video game market, selling online multiplayer game
    time and prepaid cards in more than 20 cities in China. The venture with Sohu takes
    the company mobile for the first time and company officials say the timing and
    the opportunity couldn't be better.



     



    According to analysts
    at Niko Partners, China
    will be home to 119 million online gamers by 2012, propelling the market to
    $8.9 billion by 2013. And Forbes reports the online gaming community is growing
    by an average of 4 million new players each month. An alliance with Sohu
    positions Pay88 to dramatically expand their reach into this massive market.



     



    Guo Fan, Chairman and
    President of Pay88, said, "Pay88's large customer base and payment
    platform makes this agreement with SOHU an exciting opportunity for both
    companies." He added, "As a result of this new relationship, Qianbao
    Technology will now be able to offer mobile games to the domestic market in China."



     



    Company officials say
    forging this agreement with Sohu represents a powerful step forward in
    expanding their footprint throughout China. Over the coming year, the
    company will continue to develop and improve its internet gaming platform,
    expand its distribution websites, and increase its overall product line, as
    well as expand into many additional cities in China.



     



    JAGUAR MINING
    ENTERPRISES INCORPORATED (OTC: JAGR)



     



    Detailed Quote: www.otcpicks.com/quotes/JAGR.php 



     



    Company Profile: http://www.otcpicks.com/jaguar-mining/jaguar-mining.htm 



     



    Jaguar Mining
    Enterprises, Inc. is an independent mining company engaged in the acquisition,
    development, and exploitation of iron ore primarily mined in Mexico. The Company
    specializes in the exploitation of iron ore mines with proven reserves. The
    Company's strategy is to locate, acquire and develop mine locations that
    contain sufficient quantities of iron ore and require minimal start-up costs.



     



    JAGR News:



     



    October 27 - Jaguar
    Mining Enterprises Files Its Initial Disclosure Statement on Pink Sheets



     



    Jaguar Mining
    Enterprises, Inc. (OTC: JAGR), an independent mining company engaged in the
    acquisition, development, and exploitation of iron ore primarily mined in
    Mexico, announced that the company has filed its Initial Information and
    Disclosure Statement through OTC Disclosure and News Service. A current
    summation of the company and its business objectives is now available on Pink
    Sheets (www.pinksheets.com) under the company's symbol, JAGR.



     



    Jaguar Mining also
    announced that it has begun discussions with a Shanghai,
    China
    based firm to act as its direct sales and marketing representative to Chinese
    steel manufacturers. Jaguar hopes to finalize terms of an agreement which will
    provide the company with its first strategic partnership in China, the
    world's largest iron ore importer. The company plans to release complete
    details once a definitive agreement has been completed.



     



    SAFEGUARD SECURITY
    HOLDINGS INCORPORATED (OTC: SSHS)



    "Up 325.81% in
    morning trading"



     



    Detailed Quote: http://www.otcpicks.com/quotes/SSHS.php



     



    Through its operating
    subsidiaries and divisions, Safeguard Security Holdings is a single source
    security solutions provider, integrating technical and physical security
    assets. The company is organized along three distinct lines of business:
    Technical Systems, Security Personnel and Security Outsourcing Solutions. Its
    operations are directed from its offices in Dallas, Texas.



     



    SSHS News:



     



    November 6 -
    Safeguard Business Unit Announces New Contract with Texas' Largest Private Utility



     



    Safeguard Security
    Holdings, Inc. (OTC: SSHS), a provider of corporate and industrial security
    systems and personnel, announces that its subsidiary, SYSTEMSgroup Protective
    Services, has entered into a five-year agreement, which began Q1 2009, to
    provide security services for one of Texas’ largest utility companies. The
    utility is a market-leading competitive retailer that provides electricity and
    related services to more than two million Texas customers.



     



    Safeguard’s CEO, R.
    Michael Lagow, stated, “The SYSTEMSgroup Protective Services division has
    provided services to this utility giant since January 2005, and we are
    delighted to be awarded a contract of this magnitude spanning five additional
    years of service. This brings over $32+ million in revenue to our
    Company." Lagow added, “Our Company continues to build its book of
    business with quality clients that recognize best value services for its
    clients. It’s what we do best!”



     



    COLUMBIA BANCORP (NASDAQ: CBBO)



    "Up 47.41% in
    morning trading"



     



    Detailed Quote: http://www.otcpicks.com/quotes/CBBO.php



     



    Columbia Bancorp is
    the bank holding company for Columbia River Bank, which operates 21 branches
    located in The Dalles (2), Hood
    River, Bend
    (3), Madras, Redmond
    (2), Pendleton, Hermiston, McMinnville, Canby, and Newberg,
    Oregon, and in Goldendale, White Salmon,
    Sunnyside, Yakima, Pasco,
    Richland, and Vancouver, Washington.
    To supplement its community banking services, Columbia River Bank also provides
    brokerage services through CRB Financial Services Team.



     



    CBBO News:



     



    August 10 - Columbia Bancorp
    Announces Filing of Form 10-Q Quarterly Report and Second Quarter 2009
    Financial Results



     



    Columbia Bancorp
    (Nasdaq: CBBO), the bank holding company for Columbia River Bank, announced a
    loss for the second quarter of 2009 of $23.3 million, or $2.31 per diluted
    share including $14.4 million in provision for loan losses, $7.2 million in
    non-recurring, non-cash income tax expense primarily related to the
    establishment of a valuation allowance against deferred tax assets and $1.4
    million in FDIC premiums and state assessments. "While the economic conditions
    continue to present challenges across the financial industry, we remain focused
    on our strategic initiative to increase liquidity through the realignment of
    the balance sheet," stated Terry L. Cochran, President and CEO. Columbia reduced its gross
    loan balances by $36.8 million to $799.6 million and increased deposits by
    $55.5 million to $992.7 million during the second quarter 2009. This
    realignment continued to improve Columbia River Bank's funding position,
    increasing liquid assets as a percentage of total assets from 10.3% as of March
    31, 2009 to 17.5% as of June 30, 2009, as well as decreasing the loan to
    deposit ratio from 88.3% to 85.5% on a linked quarter basis. "I am very
    pleased with the efforts of our branch and administration teams in continuing
    to provide excellent customer service. We particularly appreciate the
    confidence of our customers, as evidenced by the opening more than 1,400 new
    accounts during the quarter," Cochran added.



     



    Columbia continues to be impacted by the U.S.
    economic condition and its negative impact on two of Columbia's primary market areas, where real
    estate values have dropped substantially. Second quarter loan loss provisions
    resulted primarily from continued declines in collateral values underlying
    residential home construction and lot development loans in those markets.
    Geographically, these loans remain concentrated in Columbia's
    Central Oregon and Portland-Vancouver
    metropolitan markets. Net charge-offs totaled $14.9 million for the second
    quarter of 2009, including charge-offs of $10.3 million related to residential
    construction loans and $2.1 million related to 1-4 family residential term
    loans. "We are proactively ensuring that our lenders and special asset
    teams continue to have the necessary resources to focus on working with
    borrowers to mitigate any potential losses, and exiting out of existing
    non-performing assets," stated Cochran.



     



    As of June 30, 2009,
    non-performing assets totaled $122.6 million, compared to $106.4 million as of
    March 31, 2009. The $16.2 million net increase in non-performing assets is
    primarily in the non-accrual loan category. Non-accrual loans continue to be
    centered in the residential sectors of the portfolio, which accounts for 66% of
    the non-accrual totals. Other real estate owned ("OREO") totaled
    $11.3 million as of June 30, 2009. During the second quarter, two OREO
    properties totaling approximately $746,000 were sold at a net gain of $20,000;
    $1.2 million of foreclosed properties were added to OREO; and an impairment
    charge of $499,000 was recognized on three properties due to declining values.



     



    Columbia's net interest income totaled $6.6 million for the second
    quarter of 2009, compared to $6.8 million for the first quarter of 2009.
    Despite total average earning assets decreasing slightly during the quarter, as
    a percentage of total average assets, average earning assets increased from
    91.75% for the first quarter of 2009 to 93.27% for the second quarter of 2009. Columbia's net interest
    margin decreased slightly to 2.74% for the second quarter of 2009 as compared
    to 2.79% on a linked quarter basis. During this same time period, the shift in
    earning asset mix from overall higher yielding loans to lower yielding cash and
    liquid investments, in direct response to Columbia's strategic initiative to
    maintain and improve liquidity, directly impacted the net interest margin.
    Additionally, Columbia
    reversed $1.4 million of interest income from loans placed on non-accrual
    status. Interest income would have been $2.7 million higher had non-accrual
    loans performed according to terms. Offsetting the lower loan yield was a
    declining cost of funds resulting from pay downs of higher cost brokered
    certificates of deposit and lower cost of funds for retail deposits. During the
    second quarter, Columbia
    reduced brokered certificates of deposit by $25.3 million that carried a
    weighted average rate of 4.26%.



     



    AXCELIS TECHNOLOGIES
    INCORPORATED (NASDAQ: ACLS)



    "Up 29.89% in
    morning trading"



     



    Detailed Quote: http://www.otcpicks.com/quotes/ACLS.php



     



    Axcelis Technologies,
    Inc., headquartered in Beverly,
    Massachusetts
    , provides
    innovative, high-productivity solutions for the semiconductor industry. Axcelis
    is dedicated to developing enabling process applications through the design,
    manufacture and complete life cycle support of ion implantation and cleaning
    systems.



     



    ACLS News:



     



    November 5 - Axcelis
    Announces Improved Financial Results for Third Quarter 2009



     



    Axcelis Technologies,
    Inc. (Nasdaq: ACLS) announced improved financial results for the third quarter
    ended September 30, 2009.



     



    The Company reported
    third quarter revenue of $35.0 million, compared to $33.6 million for the
    second quarter of 2009. Net loss for the third quarter was $15.9 million, or $0.15
    per share. This compares to a net loss for the second quarter of 2009 of $22.4
    million, or $0.22 per share of which $4.1 million ($.04 per share) was
    attributable to restructuring charges. In the corresponding quarter for the
    previous year, the Company reported revenue of $46.5 million, and a net loss of
    $24.7 million, or $0.24 per share.



     



    Balance Sheet



     



    Cash and cash
    equivalents, including restricted cash, were $48.5 million at September 30,
    2009. Cash burn ($8.5 million in the third quarter of which $2.4 million was
    attributable to restructuring costs) continues to decline and we expect to
    approach cash flow break even in the fourth quarter of 2009. The Company ended
    the quarter with working capital of $177.5 million. Working capital management
    remains a focus to enhance cash flow. During 2009 the Company has reduced
    inventories by $17.2 million through the sale of product on hand.



     



    Commenting on the
    Company's performance, Mary Puma, chairman and CEO, stated, "We're pleased
    to report improving financial results this quarter in terms of reducing our
    losses and slowing our cash burn. Actions taken to reduce operating expenses
    and increase efficiencies throughout the organization are having, and will
    continue to have, a positive effect on cash flow and profitability. In fact, we
    expect to approach cash breakeven in the fourth quarter, as increased fab
    utilization drives aftermarket business and new systems orders." She
    added, 'We've also made solid progress with our product portfolio through enhancements
    to productivity and advanced process capabilities. Consequently, we are well
    positioned to meet customers' technology demands and benefit from enhanced
    earnings leverage moving into 2010."



     



    CORD BLOOD AMERICA
    INCORPORATED (OTCBB: CBAI)



    "Up 13.73% in
    morning trading"



     



    Detailed Quote: http://www.otcpicks.com/quotes/CBAI.php 



     



    Cord Blood America is
    the parent company of CorCell, which facilitates umbilical cord blood stem cell
    preservation for expectant parents and their children. Its mission is to be the
    most respected stem cell preservation company in the industry. Collected
    through a safe and non-invasive process, cord blood stem cells offer a powerful
    and potentially life-saving resource for treating a growing number of ailments,
    including cancer, leukemia, blood, and immune disorders.



     



    CBAI News:



     



    November 6 - Cord
    Blood America Updates
    Advantages of Las Vegas
    Laboratory in Analyst Interview; Explains Recent S1 Filing



     



    Cord Blood America,
    Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company
    focused on bringing the life saving potential of stem cells, a biological
    insurance policy for families nationwide and internationally, recently
    addressed shareholder questions about its new laboratory in Las Vegas, and its
    recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder
    and CEO, by analyst Francis Gaskins.



     



    The entire interview
    is available at www.stoxrox.com/cbai-11-5-09.mp3.



     



    In the interview Mr.
    Schissler said:



     



    * The S1 registration
    statement withdraws an earlier filing, saves the Company money, and will not be
    used until necessary.



    * The new Las Vegas lab reduces
    costs because lab services will no longer be outsourced.



    * This subsequently
    will increase gross profits for the Company and its shareholders.



    * The new lab
    increases the Company's revenue streams, with significant new opportunities to
    store other biological products and other lines of stem cells including stem
    cells from other companies.



    * Finally, the new
    lab gives Cord Blood America the opportunity to work with other stem cell
    companies in research and development.



     



    ENDEAVOR POWER
    CORPORATION (OTCBB: EDVP)



    "Up 45.82% in
    morning trading"



     



    Detailed Quote: http://www.otcpicks.com/quotes/EDVP.php



     



    Endeavor Power Corp.
    is an independent, energy company engaged in the acquisition, exploitation and
    development of oil and natural gas properties in the United States. Endeavor's objective
    is to seek out and develop opportunities in the oil and natural gas sectors
    that represent a low risk opportunity. Endeavor also aims to define larger
    projects that can be developed with Joint Venture partners.



     



    EDVP News:



     



    October 14 - Endeavor
    Announces Corporate Update



     



    Endeavor Power Corp.
    (OTCBB: EDVP) (the "Company") announced that its Board of Directors
    approved a 1 for 10 reverse stock split. The reverse stock split will reduce
    the number of issued and outstanding shares of the Company. The reverse stock split
    is subject to approval by the Company's stockholders and certain other
    conditions. There can be no assurances at this time that the reverse stock
    split will be consummated. A special stockholders meeting to consider this
    matter is tentatively scheduled for some time during the 4th quarter, with the
    exact timing dependent on the SEC's review of the necessary filings.



     



    The Company will file
    an Information Statement with the SEC that describes the reverse stock split in
    greater detail, with such Information Statement addressing other corporate
    actions as well such as reelection of the Company's officers and directors and
    approval of an Employee Stock Option Plan. Upon SEC approval, the Company will
    mail a copy of the Information Statement to all stockholders of record
    announcing the special meeting.



     



    Brandon Toth,
    Endeavor's President and chief executive officer, stated, "It is the
    opinion of the Company's Board of Directors that a reverse stock split is in
    the best interests of the stockholders as it will allow the Company to more
    aggressively pursue potential oil and gas acquisitions, or even to consider
    possible merger candidates."



     



    The announcement of
    the proposed reverse stock split described above is not a solicitation of a
    proxy. The Company will hold a special meeting of stockholders to vote on the
    transaction. Prior to the meeting, the Company will mail to the Company's
    stockholders an Information Statement that will contain important information
    regarding the meeting and the transaction, including, among other things, the
    recommendation of the Company's Board of Directors regarding the transaction.
    Stockholders of the Company are advised to read the materials. Copies of the
    Information Statement materials, and any amendments or supplements thereto, will
    be available without charge at the SEC's website.



     



    SUNESIS
    PHARMACEUTICALS INCORPORATED (NASDAQ: SNSS)



    "Up 6.74% in
    morning trading"



     



    Detailed Quote: http://www.otcpicks.com/quotes/SNSS.php 



     



    Sunesis is a
    biopharmaceutical company focused on the development and commercialization of
    new oncology therapeutics for the treatment of solid and hematologic cancers.
    Sunesis has built a highly experienced cancer drug development organization
    committed to advancing its lead product candidate, voreloxin, in multiple
    indications to improve the lives of people with cancer.



     



    SNSS News:



     



    November 5 - Sunesis'
    Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia



     



    Sunesis
    Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that the U.S. Food and Drug
    Administration has granted voreloxin orphan drug designation for the treatment
    of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2
    clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1,
    of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from
    standard induction chemotherapy and a study evaluating voreloxin in combination
    with cytarabine in relapsed/refractory AML.



     



    "This
    designation recognizes the acute need for more options in treating this
    poor-prognosis disease," stated Steven B. Ketchum, Ph.D., Senior Vice
    President of Research and Development at Sunesis. "We believe voreloxin
    has the potential to impact the standard of care for AML and we continue to be
    encouraged by our progress. We are finalizing a registration strategy for
    voreloxin in AML and anticipate launching a pivotal trial in 2010."



     



    Orphan drug
    designation is granted by the FDA Office of Orphan Drug Products to novel drugs
    or biologics that treat a rare disease or condition affecting fewer than
    200,000 patients in the U.S.
    The designation provides eligibility for a seven-year period of market
    exclusivity in the United
    States
    after product approval and an
    exemption from user fees.



     



    ABOUT VORELOXIN



     



    Voreloxin is a
    first-in-class anticancer quinolone derivative, or AQD, a class of compounds
    that has not been used previously for the treatment of cancer. Voreloxin both
    intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent,
    site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently
    being evaluated in a Phase 2 clinical trial (known as the REVEAL-1 trial) in
    previously untreated elderly AML patients and in a Phase 1b/2 clinical trial
    combining voreloxin with cytarabine for the treatment of patients with
    relapsed/refractory AML, as well as in an ongoing Phase 2 single-agent trial in
    platinum-resistant ovarian cancer.



     



    ABOUT ACUTE MYELOID
    LEUKEMIA



     



    AML is a rapidly
    progressing cancer of the blood characterized by the uncontrolled proliferation
    of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society
    estimates that nearly 13,000 new cases of AML will be diagnosed and
    approximately 9,000 deaths from AML will occur in the U.S. in 2009.
    AML is generally a disease of older adults, and the median age of a patient
    diagnosed with AML is about 67 years. A majority of elderly patients are not
    considered candidates for standard induction therapy or decline therapy,
    resulting in an acute need for new treatment options.



     



    OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper,
    TX 75078
    ,
    Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This
    email address is being protected from spam bots, you need Javascript enabled to
    view it.





    DO NOT BASE ANY
    INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not
    registered as a securities broker-dealer or an investment adviser either with
    the U.S. Securities and Exchange Commission (the "SEC") or with any
    state securities regulatory authority. We are neither licensed nor qualified to
    provide investment advice. OTCPicks.com makes no recommendation that the
    purchase of securities of companies profiled in this web site is suitable or
    advisable for any person or that an investment such securities will be
    profitable. In general, given the nature of the companies profiled and the lack
    of an active trading market for their securities, investing in such securities
    is highly speculative and carries a high degree of risk. You are receiving this
    email because you have registered on OTCPicks.com or one of our affiliate
    companies.





    The information
    contained in our report should be viewed as commercial advertisement and is not
    intended to be investment advice. The report is not provided to any particular
    individual with a view toward their individual circumstances. The information
    contained in our report is not an offer to buy or sell securities. We
    distribute opinions, comments and information free of charge exclusively to
    individuals who wish to receive them.





    Our newsletter and
    website have been prepared for informational purposes only and are not intended
    to be used as a complete source of information on any particular company. An
    individual should never invest in the securities of any company profiled based
    solely on information contained in our reports. Individuals should assume that
    all information contained in the report about profiled companies is not trustworthy
    unless verified by their own independent research.





    Any individual who
    chooses to invest in any securities should do so with caution. Investing in
    securities is speculative and carries a high degree of risk; you may lose some
    or all of the money that is invested. Always research your own investments and
    consult with a registered investment advisor or licensed stock broker before
    investing.





    Information contained
    in our report will contain "forward looking statements" as defined
    under Section 27A of the Securities Act of 1933 and Section 21B of the
    Securities Exchange Act of 1934. Subscribers are cautioned not to place undue
    reliance upon these forward looking statements. These forward looking
    statements are subject to a number of known and unknown risks and uncertainties
    outside of our control that could cause actual operations or results to differ
    materially from those anticipated. Factors that could affect performance
    include, but are not limited to, those factors that are discussed in each profiled
    company's most recent reports or registration statements filed with the SEC.
    You should consider these factors in evaluating the forward looking statements
    included in the report and not place undue reliance upon such statements. We
    are committed to providing factual information on the companies that are
    profiled. However, we do not provide any assurance as to the accuracy or
    completeness of the information provided, including information regarding a
    profiled company's plans or ability to effect any planned or proposed actions.
    We have no first-hand knowledge of any profiled company's operations and
    therefore cannot comment on their capabilities, intent, resources, nor
    experience and we make no attempt to do so. Statistical information, dollar
    amounts, and market size data was provided by the subject company and related
    public information sources which we believe to be reliable but we cannot
    guarantee the accuracy of the information. To the fullest extent of the law, we
    will not be liable to any person or entity for the quality, accuracy,
    completeness, reliability, or timeliness of the information provided in the
    report, or for any direct, indirect, consequential, incidental, special or
    punitive damages that may arise out of the use of information we provide to any
    person or entity (including, but not limited to, lost profits, loss of
    opportunities, trading losses, and damages that may result from any inaccuracy
    or incompleteness of this information). We encourage you to invest carefully
    and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.





    Disclosure:
    OTCPicks.com has been compensated ten thousand dollars by the company for a
    current BMGP advertising and promotional services. OTCPicks has been
    compensated ten million free trading shares from a non-controlling third Party
    (Microcap Management) for DVME advertising and promotional services. OTCPicks
    has been compensated seven thousand five hundred dollars from a non-controlling
    third party (BlueWave Advisors) for AMNP advertising and promotional services.
    OTCPicks.com has been compensated seven thousand five hundred dollars by a
    third party for BMGP advertising and promotional services. OTCPicks.com has
    been compensated six thousand five hundred dollars by a third part (Ladasa
    Inc.) for a two-week PAYI advertising and promotional program. OTCPicks.com has
    been compensated two hundred thousand free trading shares by a third party
    (Microcap Management) for JAGR advertising and promotional services. This
    compensation constitutes a conflict of interest as to our ability to remain
    objective in our communication regarding the profiled company. OTCPicks.com is
    a website partially owned by BlueWave Advisors, LLC, a financial public
    relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates
    will hold positions in the company profiled and may buy or sell securities at
    any time without notice.



     





    • Print
    • Bookmark and Share

    Comments

     



     

     

    Recent Stocks Posts